FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs - FDA Press Releases

FDA takes steps to enhance transparency of clinical trial data used in support of new drug approvals

from Food and Drug Administration--Press Releases http://ift.tt/2D96JjF
via IFTTT